What is a stock summary page? Click here for an overview.
Business Description
GeneOne Life Science Inc
ISIN : KR7011000007
Compare
Compare
Traded in other countries / regions
011000.Korea Index Membership
KOSPI IPO Date
1987-11-16Description
GeneOne Life Science Inc is engaged in the research, development, and manufacturing of biopharmaceutical products including vaccines for treating pandemic influenza, seasonal influenza for old people, and chronic hepatitis B and C as well cancers and other infectious diseases.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.06 | |||||
| Equity-to-Asset | 0.57 | |||||
| Debt-to-Equity | 0.32 | |||||
| Debt-to-EBITDA | -0.95 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -1.96 | |||||
| Beneish M-Score | -3.85 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -4.8 | |||||
| 3-Year EBITDA Growth Rate | -60.9 | |||||
| 3-Year EPS without NRI Growth Rate | -33 | |||||
| 3-Year FCF Growth Rate | 40.8 | |||||
| 3-Year Book Growth Rate | -26.2 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 58.93 | |||||
| 9-Day RSI | 51.31 | |||||
| 14-Day RSI | 48.01 | |||||
| 3-1 Month Momentum % | -22.28 | |||||
| 6-1 Month Momentum % | -13 | |||||
| 12-1 Month Momentum % | -8.39 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.67 | |||||
| Quick Ratio | 0.29 | |||||
| Cash Ratio | 0.04 | |||||
| Days Inventory | 125.49 | |||||
| Days Sales Outstanding | 62.2 | |||||
| Days Payable | 110.69 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.1 | |||||
| Shareholder Yield % | -8.45 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -30.43 | |||||
| Operating Margin % | -134.93 | |||||
| Net Margin % | -135.88 | |||||
| FCF Margin % | -54.38 | |||||
| ROE % | -48.11 | |||||
| ROA % | -32.66 | |||||
| ROIC % | -36.16 | |||||
| 3-Year ROIIC % | -171.4 | |||||
| ROC (Joel Greenblatt) % | -40.13 | |||||
| ROCE % | -38.53 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 4.48 | |||||
| PB Ratio | 1.88 | |||||
| Price-to-Tangible-Book | 1.88 | |||||
| EV-to-EBIT | -3.99 | |||||
| EV-to-EBITDA | -6.5 | |||||
| EV-to-Revenue | 5.2 | |||||
| EV-to-FCF | -9.07 | |||||
| Price-to-GF-Value | 0.61 | |||||
| Price-to-Median-PS-Value | 0.83 | |||||
| Earnings Yield (Greenblatt) % | -25.1 | |||||
| FCF Yield % | -12.11 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
GeneOne Life Science Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 35,720.099 | ||
| EPS (TTM) (â‚©) | -610 | ||
| Beta | 0.65 | ||
| 3-Year Sharpe Ratio | -1.11 | ||
| 3-Year Sortino Ratio | -1.47 | ||
| Volatility % | 63.05 | ||
| 14-Day RSI | 48.01 | ||
| 14-Day ATR (â‚©) | 76.205473 | ||
| 20-Day SMA (â‚©) | 2021.3 | ||
| 12-1 Month Momentum % | -8.39 | ||
| 52-Week Range (â‚©) | 1830 - 4735 | ||
| Shares Outstanding (Mil) | 79.83 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
GeneOne Life Science Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
GeneOne Life Science Inc Stock Events
| Event | Date | Price (â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
GeneOne Life Science Inc Frequently Asked Questions
What is GeneOne Life Science Inc(XKRX:011000)'s stock price today?
The current price of XKRX:011000 is â‚©2010.00. The 52 week high of XKRX:011000 is â‚©4735.00 and 52 week low is â‚©1830.00.
When is next earnings date of GeneOne Life Science Inc(XKRX:011000)?
The next earnings date of GeneOne Life Science Inc(XKRX:011000) is .
Does GeneOne Life Science Inc(XKRX:011000) pay dividends? If so, how much?
GeneOne Life Science Inc(XKRX:011000) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers